MGMarion Boyd Gillespie

Marion Boyd Gillespie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marion Boyd Gillespie has a total of 170 co-authors. Here are the top co-authors by number of shared publications:

  • Shaun A. Nguyen

    Department of Otolaryngology - Head and Neck Surgery, The Medical University of South Carolina, Charleston, South Carolina

    10 shared publications
  • Terry A. Day

    From the Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A.

    6 shared publications
  • Anand K. Sharma

    From the Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, U.S.A.

    4 shared publications
  • Adrian A. Ong

    Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas

    3 shared publications
  • David R. White

    Department of Otolaryngology‐Head &Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A

    3 shared publications
  • Joshua D. Hornig

    Department of Otolaryngology–Head and Neck Surgery and Pathology, Medical University of South Carolina, Charleston, SC

    3 shared publications

Latest Publications

  • Open Access

    Cardio‐Protective Effect of GLP ‐1 Agonists in OSA Patients: A Study of Cardiovascular Risk

    by Morgan Lane, Alex Jin, Boston Andersen, Alec Kadrie, Sage Hebert, Evan Thomson, M. Boyd Gillespie

    Objective: Obstructive sleep apnea (OSA) is highly associated with obesity and often results in significant cardiovascular complications. This study aimed to assess cardiovascular outcomes in OSA patients treated with GLP‐1 agonists (GLP1a) versus CPAP. Methods: This retrospective cohort analysis using TriNetX datasets (2014–2024) compared cardiovascular outcomes between four pairs of cohorts, after propensity score matching (PSM): OSA+CPAP +/− GLP1a, OSA+Obesity + CPAP +/− GLP1a, OSA—CPAP +/− GLP1a, and OSA+Obesity—CPAP +/− GLP1a. Outcomes of interest include myocardial infarction, heart failure, stroke, cardiac arrest, ventricular arrhythmias, atrial fibrillation/flutter, pulmonary hypertension, and percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG). Results: In the non‐CPAP cohort, GLP‐1a therapy showed decreased risks of myocardial infarction (RR 0.650 [0.523–0.808]), heart failure (RR 0.500 [0.357–0.701]), cardiac arrest (RR 0.300 [0.199–0.450]), ventricular arrhythmias (RR 0.385 [0.278–0.532]), atrial fibrillation/flutter (RR 0.833 [0.762–0.912]), and PCI/CABG (RR 0.333 [0.163–0.681]). No significant differences were observed in stroke or pulmonary hypertension between GLP1+ and GLP1‐ groups in this cohort. Among patients using CPAP, GLP1a use was associated with a decreased risk of atrial fibrillation/flutter (RR 0.700 [0.542–0.905]), with no other differences observed. Conclusion: Our study indicates that GLP‐1 agonists may offer cardioprotective benefits not achieved with CPAP therapy in OSA patients. Our study indicates that a GLP‐1 agonist prescription may be associated with improved cardiovascular outcomes; these associations were not observed with CPAP therapy prescription in OSA patients. Additional research is required to determine whether obesity status modulates the observed benefits among patients with OSA.

  • Open Access

    Effect of Malocclusion on Response to Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea

    by Emily R. Baker, Meghana Chanamolu, David M. Weatherford, M. Boyd Gillespie

    Introduction: Variations in craniofacial anatomy have been associated with the development of obstructive sleep apnea (OSA) and may impact the response to medical and surgical therapies. This study aims to evaluate the effect of malocclusion on the clinical response to hypoglossal nerve stimulator (HNS) therapy. Methods: This is a retrospective cohort study evaluating patients with OSA who underwent HNS placement between May 2017 and December 2022. Occlusion was determined using Angle's Classification Criteria, and outcome measures including preoperative and postoperative Apnea‐Hypopnea Index (AHI), lowest O2 saturation (SpO2), and Epworth Sleepiness Scale (ESS) scores were analyzed. Two cohorts were created by grouping patients with normal occlusion and those with class II or class III malocclusion. Results: Of the 64 patients included in the study, 49 had normal occlusion and 15 had malocclusion. There was no significant difference in age, BMI, or pre‐operative AHI between groups. The median AHI in those with normal occlusion was significantly reduced with HNS therapy, going from 35.9 to 8.2 ( p < 0.0001), while the reduction in those with malocclusion was not significant (32.8 vs. 24.0, p = 0.1258). 75.5% of those with normal occlusion met criteria for surgical success as defined by Sher et al. while success was only achieved in 33.3% of those with malocclusion ( p < 0.01). Conclusion: This study suggests patients with malocclusion may experience diminished efficacy to HNS therapy. This information may help identify individuals who are less likely to benefit from HNS therapy or who may require alternative (maxillomandibular advancement) or combination therapy (HNS with oral appliance). Level of Evidence: 3.

  • Comparing Hyoid Suspension Approaches in Multilevel Sleep Surgery: A Systematic Review and Meta‐Analysis

    by David Weatherford, Joel James, Harrison Smith, Sean Graham, Emily Baker, M. Boyd Gillespie

    Objective: Hyoid suspension is a method used to address hypopharyngeal obstruction in multilevel surgery for obstructive sleep apnea (OSA). The procedure involves suspending the hyoid bone to either the mandible or thyroid cartilage, determined by surgeon preference. This meta‐analysis aims to compare the effectiveness of these two approaches in multi‐level sleep surgery. Data Sources: PubMed, Embase, Scopus, and The Cochrane Library. Review Methods: All studies underwent a 2‐stage blinded screening, extraction, and evaluation process. Primary outcomes of the study included pre‐ and postoperative apnea hypopnea index (AHI), Sher surgical success rate (≥50% reduction in AHI and postoperative AHI < 20), and changes to Epworth Sleepiness Scale (ESS) Score. Results: Database searches yielded 1502 studies with 74 full‐text articles screened, and 21 studies ultimately included. In patients who underwent hyothyroidpexy and palatal surgery (n = 582), the average AHI was reduced 20.98 (confidence interval 16.87, 25.08), ESS score improved by 5.99 [4.35, 7.63], and 57.5% met Sher criteria for surgical success. Patients who received hyomandibular suspension (n = 141) achieved an average AHI reduction of 29.21 [20.87, 37.55], improvement in ESS by 4.4 [1.33, 7.51], and Sher success rate of 73.8%. Although improvement in AHI and ESS scores were not statistically significant between groups, the proportion of patients meeting Sher Criteria success was greater for hyomandibular suspension ( P = .006) Conclusion: The results of this study show that both methods of hyoid suspension are effective in treating OSA when used as a component of multilevel sleep surgery but suggests that hyomandibular suspension may provide greater improvement than hyothyroidpexy.

  • Open Access

    A Prospective Cohort Study of Aesthetic Outcomes Following Hyoid Myotomy and Suspension for Obstructive Sleep Apnea

    by Chad A. Nieri, Stephen F. White, Michael Eggerstedt, Meghana Chanamolu, Ezer H. Benaim, Raj Dedhia, M. Boyd Gillespie

    Objective: To evaluate subjective and objective submental/neck aesthetic outcomes after hyoid myotomy and suspension (HMS) performed for obstructive sleep apnea (OSA). Methods: Single‐blind, single‐center, prospective cohort study including 20 adults undergoing HMS (active) and 11 adults undergoing septoplasty (control) between July 2020 and November 2022. Participants completed FACE‐Q Neck and Area Under Chin modules and underwent standardized frontal and lateral photography preoperatively and 6 weeks postoperatively. Primary outcomes were change in cervicomental angle (CMA), hyomental distance (HMD), Rainbow Scale (RS), and FACE‐Q scores; frontal neck width was a secondary outcome. Between‐group differences in change were assessed using ANCOVA adjusting for age and baseline values. Results: HMS participants were older than controls (median 67 [IQR 54–74] vs. 47 [35–56] years; p = 0.021). In adjusted analyses, HMS demonstrated greater improvement than controls in FACE‐Q Area Under Chin (adjusted mean difference + 17.48; 95% CI, 2.2 to 32.8; p = 0.022), FACE‐Q Neck (+14.60; 95% CI, 2.1 to 27.2; p = 0.025), and CMA (−10.17°; 95% CI, −19.4 to −1.0; p = 0.026). Differences were not significant for RS (−0.36; p = 0.311), HMD (−0.69 cm; p = 0.095), or neck width (−0.20 cm; p = 0.547). Conclusion: In this feasibility cohort with 6‐week follow‐up, HMS for OSA was associated with improved patient‐reported aesthetic satisfaction and a greater reduction in CMA compared with septoplasty controls. Larger studies with longer follow‐up are needed to assess durability and longer‐term outcomes. Level of Evidence: 3.

  • Open Access

    The Role of Hyoid Suspension in Multilevel Sleep Surgery for Obstructive Sleep Apnea

    by Emily R. Baker, David M. Weatherford, Joel James, M. Boyd Gillespie

    Purpose of Review: This review examines the available literature on hyoid suspension in the context of multilevel sleep surgery for obstructive sleep apnea. Topics covered include surgical techniques, surgical success rates, nature and rate of complications, and areas of interest for future investigation. Recent Findings: Hyoid suspension is significantly less invasive than other surgical interventions targeting hypopharyngeal collapse such as genioglossus advancement or midline glossectomy. Published data suggest similar or superior efficacy compared to these approaches. Like these other approaches, results of hyoid suspension are most consistent when combined with palatal surgery. Emerging data suggests that hyoid suspension to the mandible may be more effective than hyoid suspension to the thyroid cartilage. Summary: Hyoid suspension is a safe and effective procedure that shows promising rates of surgical success when combined with uvulopalatopharyngoplasty. Future research should focus on comparing hyothyroid and hyomandibular suspension and identifying patient-specific factors that are associated with surgical success.


  • Open Access

    The Auriculotemporal Nerve: A Comprehensive Review of Its Anatomical Variation and Clinical Manifestations

    by Alec Kadrie, Patrick Toomey, Joseph Callaway, Marion Boyd Gillespie, John D. Boughter

    Objectives: Various studies have described anatomical variations of the auriculotemporal nerve (ATN), starting with its initial nerve roots and relationship to the middle meningeal artery (MMA). Despite its crucial role in innervating various regions, the precise anatomical course of ATN and its variants remains uncertain. This study aims to provide a comprehensive review of the ATN, including its anatomical course, variations, and clinical significance, particularly in relation to head and neck surgery.Methods: A systematic literature review was conducted using Medline, Embase, and PubMed databases to identify all articles describing the clinical anatomy of ATN. This search strategy adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analysis) guidelines. English‐language and human studies were selected. Additionally, dissections were performed on three human cadavers to obtain representative images.Results: ATN exhibited 1–5 roots, most commonly two (52%), relevant to surgical planning and perineural tumor spread. An inferior alveolar root origination was present in 32.6% of specimens, potentially contributing to unexpected anesthesia or neuralgia. ATN enclosed the MMA in 72.2%, often forming a triangle/V‐shaped (61.4%) or “buttonhole” (1.7%) configuration. TMJ innervation was present in all specimens, with 5.8% of branches penetrating the lateral pterygoid, implicating TMJ pain. ATN branches crossed the superficial temporal artery in 73% of cases, relevant to migraine decompression. Parotid branches originated 2–16 mm from the tragus, impacting Frey's syndrome and tumor tracking. Facial nerve communication (> 90%) and greater auricular nerve connection (up to 30%) may underlie atypical facial pain and extended anesthesia fields.Conclusions: Our review reveals considerable diversity in ATN origins, branching patterns, and relationships with adjacent vessels, challenging traditional anatomical depictions. Understanding these variations is crucial for managing compression and entrapment syndromes like temporomandibular disorder and surgical procedures such as parotidectomy, where iatrogenic damage can lead to complications such as Frey Syndrome.Level of Evidence: 3.


  • Open Access

    Multicentre study conducted across centres in the USA, Europe and Australia to assess the safety and effectiveness of a bilateral hypoglossal nerve stimulation system for the treatment of obstructive sleep apnoea in adults: a protocol for a pivotal, multicentre, open-label, single-arm study

    by B Tucker Woodson, Maria V Suurna, M Boyd Gillespie, Tod C Huntley, Melyssa Hancock, Angela Santos, Jeyakumar Subbaroyan, Fatima Makori, Grégoire Fesneau, Clemens Heiser, et al.

    Introduction: Obstructive sleep apnoea (OSA) is characterised by blood oxygen desaturations and sleep disruptions manifesting undesirable consequences. Existing treatments including oral appliances, positive airway pressure (PAP) therapy and surgically altering the anatomy of the pharynx have drawbacks including poor long-term adherence or often involving irreversible, invasive procedures. Bilateral hypoglossal nerve stimulation (HNS BL ) is a new treatment for managing OSA, and this study is intended to determine whether an HNS BL system is a safe and effective treatment option for adults with OSA. Methods and analysis: This is a pivotal, multicentre, prospective, single-arm study of HNS BL in PAP-intolerant adults with moderate to severe OSA. The device is activated 2 months after implantation with stimulation settings optimised before the final 12-month sleep study. At 12 months, the two coprimary effectiveness endpoints are the percentage of responders based on reduction in the Apnoea-Hypoponea Index, with hypopnoeas associated with 4% oxyhaemoglobin desaturation, and the Oxygen Desaturation Index, using drops in oxygen concentration >4% from baseline (ODI4). Secondary effectiveness endpoints include mean changes in quality-of-life assessments (daytime sleepiness and its effect on activities of daily living, OSA-specific quality of life, daytime sleepiness), levels of intermittent hypoxia, change in hypoxaemic burden and OSA severity. Ethics and dissemination: The Food and Drug Administration, Advarra Institutional Review Board (IRB), University of Tennessee HSC IRB, University of Pennsylvania IRB, Weill Cornell Medicine IRB, Medical College of Wisconsin/Froedert Hospital, Human Research Protections Programme Vanderbilt University, St. Vincent’s Hospital Melbourne Human Research Ethics Committee, Ethisch Comite Universitair Ziekenhuis Antwerpen and Technische Universitat Munchen reviewed and approved this protocol. Study results will be disseminated through journal publications, updates to ClinicalTrials.gov and the Nyxoah website, and presentations at meetings and conferences. Trial registration number: NCT03868618 .


  • Outcomes of the salivary-oral health impact profile (S-OHIP) for chronic salivary disorders

    by Kimberly K. Coca, Leighton Reed, Stephanie Horton, M. Boyd Gillespie


  • High-intensity focused ultrasound for benign thyroid nodules: Systemic review and meta-analysis

    by Ezer H. Benaim, Chad Nieri, Madhu Mamidala, Michael J. Herr, Anthony Sheyn, M. Boyd Gillespie


  • Top Cited Papers

    Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer Patients

    by Maggie A. Kuhn, M. Boyd Gillespie, Stacey L. Ishman, Lisa E. Ishii, Rebecca Brody, Ezra Cohen, Shumon I. Dhar, Kate Hutcheson, Gina Jefferson, Felicia Johnson, et al.

    Objective: To develop an expert consensus statement (ECS) on the management of dysphagia in head and neck cancer (HNC) patients to address controversies and offer opportunities for quality improvement. Dysphagia in HNC was defined as swallowing impairment in patients with cancers of the nasal cavity, paranasal sinuses, nasopharynx, oral cavity, oropharynx, larynx, or hypopharynx.Methods: Development group members with expertise in dysphagia followed established guidelines for developing ECS. A professional search strategist systematically reviewed the literature, and the best available evidence was used to compose consensus statements targeted at providers managing dysphagia in adult HNC populations. The development group prioritized topics where there was significant practice variation and topics that would improve the quality of HNC patient care if consensus were possible.Results: The development group identified 60 candidate consensus statements, based on 75 initial proposed topics and questions, that focused on addressing the following high yield topics: (1) risk factors, (2) screening, (3) evaluation, (4) prevention, (5) interventions, and (6) surveillance. After 2 iterations of the Delphi survey and the removal of duplicative statements, 48 statements met the standardized definition for consensus; 12 statements were designated as no consensus.Conclusion: Expert consensus was achieved for 48 statements pertaining to risk factors, screening, evaluation, prevention, intervention, and surveillance for dysphagia in HNC patients. Clinicians can use these statements to improve quality of care, inform policy and protocols, and appreciate areas where there is no consensus. Future research, ideally randomized controlled trials, is warranted to address additional controversies related to dysphagia in HNC patients.